Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Learn more about our approach to innovation, building companies, and pioneering the future of human health, sustainability, and AI in this @BostonGlobe piece by @ScottKirsner on Flagship and our recent capital raise of $3.6 billion: https://t.co/HulujjYzmT
Flagship Founder & CEO @NoubarAfeyan shares how we’re pioneering breakthrough innovations in human health and sustainability supported by our most recent capital raise in this @BloombergTV interview with @flacqua: https://t.co/j3vYGmB34F
‘They go for blockbusters’: How Flagship Pioneering built its unique success in life sciences https://t.co/D7s89rumDy
Flagship Pioneering has announced a significant capital raise of $3.6 billion, which will be used to advance its innovative bioplatforms and new modalities of medicine. The funding will also support the development of the Octavia™ platform, aimed at creating variant-resilient vaccines to protect humanity against rapidly-evolving viruses, with funding from @CEPIvaccines. The announcement was highlighted in a recent interview with Flagship Founder and CEO Noubar Afeyan, who emphasized the company's commitment to pioneering breakthrough innovations in human health and sustainability.